PRA International opens early phase clinical research centre in Hungary
This article was originally published in Scrip
Executive Summary
The US CRO PRA International has opened a Phase I clinical trial facility in Budapest, Hungary, which will provide a "unit-on-demand" service to enhance its capabilities for early-development trials, the company said.